Back to VRTX
ProShare Advisors LLC VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
8
Latest value
$153.8M
Q3 2026
Peak value
$207.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $130.7M |
| Q3 2025 | $276K |
| Q4 2025 | $207.2M |
| Q4 2025 | $256K |
| Q1 2026 | $166.8M |
| Q1 2026 | $121K |
| Q2 2026 | $143M |
| Q3 2026 | $153.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153.8M | 294.1K | — | — |
| Q2 2026 | $143M | 287.8K | — | — |
| Q1 2026 | $121K | 10.2K | — | — |
| Q1 2026 | $166.8M | 373.5K | — | — |
| Q4 2025 | $256K | 12.8K | — | — |
| Q4 2025 | $207.2M | 457.0K | — | — |
| Q3 2025 | $276K | 11.1K | — | — |
| Q3 2025 | $130.7M | 333.7K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B